Debora Dumont is managing director and cofounder of Bioqube Ventures, a life sciences venture creation and investment firm. In 2016, Bioqube Ventures partnered with Janssen Pharmaceutica NV (Janssen), part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to act as the independent management arm leading the new Johnson & Johnson Innovation, JLINX initiative. Through this partnership, Bioqube Ventures ran the day to day operations of JLINX, including managing the investment portfolio and relationships with external venture investors, involvement in identifying, securing and investing in new companies, and supporting the overall scale-up of the new initiative. After a successful launch and hosting of 10 companies, the JLINX Incubator transitioned into the first JLABS in Europe, JLABS @ BE in March 2018.
Debora previously served as Head of Health & Care at LRM, a Belgium-based private equity and venture capital firm. In this position, she served as a board member on several biotech companies and was involved in a series of international venture capital transactions. Prior to joining LRM, between 2007 and 2010, Debora was a business developer at the Biomedical Research Institute of Hasselt University and manager of the life sciences cluster organization LifeTechLimburg (now Happy Aging - LifeTechValley).
Debora has a PhD in Biomedical Sciences from Hasselt University and holds a Masters degree in Bioscience Engineering from K.U. Leuven.
MEET DEBORAH DUMONT AT #KFG2018
Deborah Dumont will be part of the panel discussion in the morning programme.